中国实用儿科杂志

• 专题笔谈 • 上一篇    下一篇

胸腔积液指标测定的临床意义

  

  1. 中国医科大学附属盛京医院小儿呼吸内科,辽宁  沈阳  110004
  • 出版日期:2017-03-06 发布日期:2017-03-14

Clinical significance of indicators detection in pleural effusions

  1. Department of Pediatric Pulmonary,Shengjing Hospital of China Medical University,Shenyang 110004,China
  • Online:2017-03-06 Published:2017-03-14

摘要:

胸腔积液是一些疾病进展过程中的并发症,其发病率近年来呈现逐年攀升的趋势。胸腔积液的病因较多,其实验室检查包括常规检查以及细胞、生化、免疫学、微生物学检查。感染是儿童胸腔积液的主要原因,针对感染性胸腔积液的分子生物学检测新技术,如聚合酶链反应技术、核酸扩增技术,及部分新型生物标记物,包括降钙素原、C反应蛋白、穿透素-3、芳香族氨基酸等,用于鉴别类肺炎性胸腔积液、结核性胸腔积液或恶性胸腔积液。通过对胸腔积液的实验室检查指标、分子生物学新技术以及新型生物标记物的临床意义进行比较分析,以期能够早期明确儿童胸腔积液的性质进行病因诊断,从而选择适宜的治疗手段,防止病情恶化并改善预后。

关键词: 胸腔积液, 鉴别诊断, 分子生物学检测技术, 生物标记物

Abstract:

Pleural effusion is one of the most common complications during the progression of some diseases,and its mobidity has been increasing for the past few years. Etiology of pleural effusion is diverse. Laboratory examinations of pleural fluid include routine,cytology,biochemistry,immunology and microbiology examination. Infecton is the major cause of pleural effusion in children. As a result,there are many molecular microbiological detection techniques for infectious pleural effusion in recent years,e.g,polymerase chain reaction,nucleic acid amplification technique. Novel biomarkers have also emerged,including procalcitonin,C reactive protein,pentraxin-3 and aromatic amino acid,et al,which can be used to distinguish parapneumonic effusion,tuberculous pleural effusion or malignant pleural effusion. Routine laboratory examinations and these novel technologies or biomarkers need to be appropriately evaluated and compared,hoping that with those indicators clinicians could  benefit in the early etiological diagnosis,and the appropriate therapeutic approaches to prevent deterioration and improve prognosis.

Key words: pleural effusion, differential diagnosis, molecular biological detection technology, biomarker